Tyson Foods Incorporated (TSN US): Profitable Growth rank of 9 was down compared to the prior period’s 3rd rank. This is poor performance compared to 560 large Cons. Staples companies worldwide.
Read More
In April 2024, we published 4 new episodes of the My Worst Investment Ever podcast. Listen to all of them here.
Read More
Nike Incorporated (NKE US): Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank. This is World Class performance compared to 950 large Cons. Disc. companies worldwide.
Read More
Adidas AG (ADS GR): Profitable Growth rank of 10 was down compared to the prior period’s 8th rank. This is poor performance compared to 950 large Cons. Disc. companies worldwide.
Read More
Bonds only diversify under low inflation. Japanese earnings almost 2x the US. The MMT inflation train. Central banks load up on gold. AI demands power.
Read More
In this episode, Bill Bellows and host Andrew Stotz discuss seeing organizations as holograms—3D images. Holograms show all parts from different views at once. Learn how using the lens of the System of Profound Knowledge lets you see the problems and opportunities for transformation.
Read More
Johnson & Johnson (JNJ US): Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank. This is World Class performance compared to 380 large Health Care companies worldwide.
Read More
Sinovac Biotech Limited (SVA US): Profitable Growth rank of 8 was same compared to the prior period’s 8th rank. This is below average performance compared to 400 medium Health Care companies worldwide.
Read More
Pfizer Incorporated (PFE US): Profitable Growth rank of 5 was down compared to the prior period’s 1st rank. This is average performance compared to 380 large Health Care companies worldwide.
Read More
AstraZeneca PLC (AZN LN): Profitable Growth rank of 4 was down compared to the prior period’s 3rd rank. This is above average performance compared to 380 large Health Care companies worldwide.
Read MoreAS SEEN ON:
